Treataware

Impact of HIV and Its Treatment on Reverse Cholesterol Transport

This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.

About this trial

This is an observational study, looking at the effect HIV treatment has on the health of our heart. The investigators are comparing how well cholesterol is processed by those not on therapy with those who are on treatment. They are also comparing those on NNRTI-based regimens with those on PI- based ones.

Background information

Cardiovascular disease is increasingly recognized to be a significant cause of morbidity and mortality among people with chronic HIV infection in the current era of effective antiretroviral therapy. Those treated with antiretroviral therapy have increased traditional cardiovascular risk factors, but whether HIV infection in and of itself confers a significant increase in cardiovascular risk is largely unknown.

Official title:Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport
What is this trial studying?Side effect management
Start date:June 2005

This may be the proposed or expected start date for trials which have not yet started.

How many participants will this trial enrol?75

The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.

Who can enrol in this trial?You may be eligible to participate in this trial if you meet the following criteria:
  • At least 18 years old
  • Have never taken HIV treatments
  • This trial is for men only
You will not be eligible to participate in this trial if you meet any of the following criteria:
  • Treatment with any form of lipid lowering drugs, including fish oils or a Body Mass Index greater than 27.
This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.
Links to further information:
Keywords:cardiovascular disease

If you are interested in enrolling in this trial

Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.

  • You can print this page to take it with you to the doctor – just use your browser's 'print' function.
  • Before making the decision to participate in any clinical research, read our background information.
  • Call the Treataware info line if you need further advice
Our free checklist guide covers the essentials of HIV treatment and care.
Get yours here.

This information was retrieved from the Treataware website (www.treataware.info) on 2 Dec 2008. For further information, please consult the website or call the NAPWA office on 02 8568 0300.